Fund raising in North Carolina’s life science sector came to a strong close for June with three filings disclosed on Thursday and Friday showing companies raised collectively some $5 million.
Read More
An academic study compared MyoStrain to traditional and conventional methods of assessing heart health and researchers concluded that while traditional methods were unable to differentiate between healthy patients and asymptomatic patients at risk of heart failure, MyoStrain could.
Read More
Peter Gaccione joins Myocardial Solutions as president to lead commercialization of cardio-oncology solution.
Read More
